A very delicate balance Could blocking lysosomal gatekeeper PIKfyve slow neurodegeneration? NewsRob MaguireNovember 17, 2021
Verge Genomics Adds Independent Director Andrew Allen, M.D., Ph.D., to its Board of Directors Press ReleaseRob MaguireSeptember 28, 2021
AUGMENTED INTELLIGENCE IN DRUG DISCOVERY XCHANGE WEST COAST 2021 SAN FRANCISCO NewsRob MaguireSeptember 21, 2021
Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform Press ReleaseRob MaguireJuly 8, 2021
Verge Genomics Presents Preclinical Data Supporting Broad-Spectrum Potential of Its Novel, Oral Antiviral at the 31st European Congress of Clinical Microbiology & Infectious Diseases EventsRob MaguireJuly 7, 2021
Verge Genomics Announces the Addition of Mario Saltarelli, M.D., Ph.D., to its Scientific Advisory Board Press ReleaseRob MaguireMay 12, 2021
Covid-19 Devastated Some Industries But Accelerated AI Use By Companies Across The Country NewsRob MaguireApril 5, 2021
Verge Genomics Announces the Addition of Steve Kanes to its Board of Directors NewsRob MaguireMarch 9, 2021
Verge Genomics Announces Research Collaboration with the Sheffield Institute for Translational Neuroscience Press ReleaseRob MaguireFebruary 2, 2021
Verge Genomics joins the Neurofilament Light Surveillance Project to Accelerate New Approaches to Diagnosing and Treating Frontotemporal Dementia Press ReleaseRob MaguireOctober 29, 2020
Verge Genomics Announces Publication of New Approach for Uncovering Novel Drug Targets from Human Genetics Press ReleaseRob MaguireOctober 5, 2020
